Literature DB >> 17041325

Another look at synovial fluid leukocytosis and infection.

Peter J Coutlakis1, W Neal Roberts, Christopher M Wise.   

Abstract

Synovial fluid white blood cell counts are considered to be useful in diagnosing infectious arthritis, however, considerable overlap exists between infectious and noninfectious types of inflammatory arthritis. We undertook this review of synovial fluid studies at our institution to better define this degree of overlap and characterize the features of infectious arthritis in relationship to synovial fluid white cell counts. The records of 202 consecutive patients with synovial fluid white blood cell counts >2000/mm were reviewed. Infectious arthritis was diagnosed in 77% (10/13) of patients with counts >100,000, 47% (8/17) in the 50,000-100,000 range, and 5% (9/172) with counts <50,000. Crystal-induced arthritis and rheumatoid arthritis made up 81% of patients in the 15,000-50,000 range. Overall, 10 of 27 (37%) cases of infectious arthritis had white cell counts >100,000, and 18 of 27 (67%) had counts >50,000. A majority of these infections (14/18) were related to Staphylococcus aureus, while 5 of 7 infections associated with counts <20,000 were associated with atypical organisms. This study confirms that a majority of patients with very high synovial fluid white blood cell counts have infectious arthritis, and that the likelihood of infection is markedly reduced, but certainly not excluded, below this level. The presence of atypical infections in a small percentage of patients with low counts emphasizes the importance of clinical judgment in evaluating all patients with inflammatory arthritis, regardless of synovial fluid white cell counts.

Entities:  

Year:  2002        PMID: 17041325     DOI: 10.1097/00124743-200204000-00001

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  15 in total

Review 1.  Management of septic arthritis: a systematic review.

Authors:  C J Mathews; G Kingsley; M Field; A Jones; V C Weston; M Phillips; D Walker; G Coakley
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

2.  Diagnosing joint infections: synovial fluid differential is more sensitive than white blood cell count.

Authors:  Sean Baran; Connie Price; David J Hak
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-12

3.  The potential use of microcalorimetry in rapid differentiation between septic arthritis and other causes of arthritis.

Authors:  E Yusuf; T Hügle; T Daikeler; C Voide; O Borens; A Trampuz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-25       Impact factor: 3.267

4.  Leukocyte Esterase and Glucose Reagent Test Can Rule in and Rule out Septic Arthritis.

Authors:  Louisa Kolbeck; Marco Haertlé; Tilman Graulich; Max Ettinger; Eduardo M Suero; Christian Krettek; Mohamed Omar
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

Review 5.  Current concepts review: septic arthritis of the knee pathophysiology, diagnostics, and therapy.

Authors:  Atesch Ateschrang; Dirk Albrecht; Steffen Schroeter; Kuno Weise; Jürgen Dolderer
Journal:  Wien Klin Wochenschr       Date:  2011-04-06       Impact factor: 1.704

6.  What's New in the Management of Bacterial Septic Arthritis?

Authors:  Sumeet Chander; Gerald Coakley
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

Review 7.  [Infections of non-prosthetically treated joints].

Authors:  O Hauschild; N P Südkamp
Journal:  Chirurg       Date:  2016-10       Impact factor: 0.955

8.  Septic arthritis in the native joint.

Authors:  Meghan B Brennan; Jennifer L Hsu
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

Review 9.  [Septic arthritis and spondylodiscitis : Rare but feared diseases].

Authors:  N Jung; S Vossen
Journal:  Z Rheumatol       Date:  2016-11       Impact factor: 1.372

Review 10.  [Applications of molecular pathology in the diagnosis of joint infections].

Authors:  J Kriegsmann; T Hopf; D Jacobs; N Arens; V Krenn; R Schmitt-Wiedhoff; M Kriegsmann; C Heisel; C Biehl; H Thabe; R P H Schmitz; M Lehmann; M Otto
Journal:  Orthopade       Date:  2009-06       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.